Niki BioSolutions (NIKI) Stock Price, News & Analysis
What Changed
- Niki BioSolutions Partners with Global Alzheimer’s Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002
- An 8,000-option director grant at Niki BioSolutions (NIKI) carries an $8.83 exercise price.
- Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research
Price Move History
- Daily moves over 5%
- 25 69 sessions, July 20, 2026 to October 23, 2026
- Largest daily move
- -24.5% close of October 12, 2026
- 1-month change
- -60.9% closing prices, September 23, 2026 to October 23, 2026
Company Description
Niki BioSolutions (NASDAQ: NIKI) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.5M.
NIKI has declined 60.9% over the past month. The last closing price was $1.83.
For FY2025, Niki BioSolutions reported net income of -$1.4M and diluted earnings per share of -$0.19.
This page collects what Stock Titan holds for NIKI, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
Niki BioSolutions (NIKI) closed at $1.83 on October 23, 2026. Over the past month, the price has lost 60.9%.
NIKI Metrics & Rankings
Price returns through October 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Niki BioSolutions has 7 recent news articles, with the latest published 2 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 4 with negative movement. Key topics include partnership. View all NIKI news →
SEC Filings
Niki BioSolutions has filed 10 recent SEC filings, including 3 Form 4, 3 Form 8-K, 2 Form S-3/A, 1 Form EFFECT. The most recent filing was submitted on October 21, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NIKI SEC filings →
Financial Highlights
net income was -$1.4M. Diluted earnings per share stood at -$0.19. The company generated -$1.8M in operating cash flow. The current ratio was 0.78, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Niki BioSolutions (NIKI) currently stands at 14.6 thousand shares, up 11.4% from the previous reporting period, representing 2.8% of the float. Since July 2026, short interest has decreased by 41.1%.
Days to Cover History
Days to cover for Niki BioSolutions (NIKI) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
NIKI Company Profile & Sector Positioning
Niki BioSolutions (NIKI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.